Zimbabwe has turned down a substantial US healthcare agreement worth $367m (£272m) over five years because of Washington's insistence on sensitive data.
This rejection was revealed following a official document dated December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "unbalanced".
An official spokesperson later explained that the US was demanding access to health data for scientific study and profit but was unwilling to guarantee the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for continued negotiations to find a agreement agreeable to all parties so the country's vital HIV programme can continue.
Wider Background
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court halted a similar health funding agreement after legal challenges were raised about the safety of citizens' medical information.
After returning to office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government deals to enhance openness and accountability.
Based on statements, 16 African countries have to date signed similar agreements, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment through US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," his statement read.
"Effectively, our country would supply the raw materials for scientific discovery with no certainty that the end products would be available to our population if a new disease outbreak arise."
Sovereignty and International Frameworks
He also pointed out that the American exit from the global health body and its pursuit of one-on-one deals were undermining frameworks already established through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage future pandemics.
"This mechanism is intended to guarantee that when a country contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," he added.
"We welcome continued discussions with our US partners on how subsequent collaboration could be structured in a way that honours the sovereignty and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but recommended that talks must proceed given that much of the nation's Aids initiatives relied on foreign aid.
"Where specific concerns exist, such as those relating to data governance or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it said.
The situation underscores the complex debate between accepting crucial international aid and safeguarding a country's data in an ever more data-driven world.